Onco-Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Kagawa 761-0793, Japan.
Mol Med Rep. 2010 Mar-Apr;3(2):301-7. doi: 10.3892/mmr_00000255.
The existence of possible threshold dose levels of genotoxic carcinogens for carcinogenesis is of particular interest for human risk assessment. Recently, no observed effect levels (NOELs) for various hepatocarcinogens have been reported. However, reports on threshold levels for lung carcinogenesis have hitherto been lacking. In the present study, we first investigated low dose response lung and colon carcinogenesis with a food-derived genotoxic carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) (0, 0.01, 0.1, 1, 10 and 100 ppm in the diet) alone for 32 weeks using female A/J mice. The endpoints were histopathologically diagnosed hyperplasias and adenomas in the lung, and aberrant crypt foci (ACF) in the colon. The results showed NOELs of 100 and 1 ppm, respectively. We next investigated the effect of additional pre-treatment with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (2 mg/mouse, single dose, intraperitoneal injection) prior to the low-dose application of MeIQx (0, 0.01, 0.1, 1, 10, 100 and 600 ppm in the diet) for 32 weeks. Lung lesions were significantly increased in the NNK + MeIQx (1 ppm) group, but not in the NNK + MeIQx (≥10 ppm) groups. Since the dose-response curve was not of so-called 'hockey stick type', it was not possible to determine a NOEL for lung tumorigenesis. Significant increase in the mRNA expression of CYP2A5, a major metabolic enzyme for NNK, was also observed in the NNK + MeIQx (1 ppm) group, and a similar pattern was noted for O6-methylguanine DNA methyltransferase (MGMT). By contrast, the formation of colon ACF showed a dose-dependent increase. The NOEL for the formation of colon ACF was considered to be 10 ppm MeIQx with NNK. These results suggest that MeIQx may have different threshold dose levels for the induction of lung tumorigenic lesions and ACF formation in the colon. Pre-treatment with NNK, a potent lung carcinogen, concealed the effects of MeIQx in the lung, but exerted minimal influence in the colon. CYP2A5 and MGMT expression may be of importance, particularly in the lung. The present study provides critical suggestions for the human risk assessment of genotoxic carcinogens.
遗传毒性致癌物致癌存在可能的阈剂量水平,这对于人类风险评估具有特别的意义。最近,已经有报道称各种肝致癌物的无观察效应水平(NOEL)。然而,迄今为止,关于肺癌发生的阈剂量水平的报告尚缺乏。在本研究中,我们首先使用源自食物的遗传毒性致癌物 2-氨基-3,8-二甲基咪唑[4,5-f]喹喔啉(MeIQx)(饮食中 0、0.01、0.1、1、10 和 100ppm)单独处理雌性 A/J 小鼠 32 周,以调查低剂量肺和结肠致癌作用,研究终点为肺组织病理学诊断的增生和腺瘤,以及结肠的异常隐窝病灶(ACF)。结果显示,NOEL 值分别为 100 和 1ppm。接下来,我们在低剂量 MeIQx(饮食中 0、0.01、0.1、1、10、100 和 600ppm)应用前,先用 4-(甲基亚硝氨基)-1-(3-吡啶基)-1-丁酮(NNK)(2mg/只,腹腔注射)进行预处理,以调查其对 MeIQx 的影响,为期 32 周。在 NNK+MeIQx(1ppm)组中,肺病变显著增加,但在 NNK+MeIQx(≥10ppm)组中未观察到这种情况。由于剂量反应曲线不是所谓的“冰球棒型”,因此无法确定肺肿瘤发生的 NOEL。在 NNK+MeIQx(1ppm)组中,也观察到 NNK 的主要代谢酶 CYP2A5 的 mRNA 表达显著增加,并且 O6-甲基鸟嘌呤 DNA 甲基转移酶(MGMT)也呈现出相似的模式。相比之下,结肠 ACF 的形成呈剂量依赖性增加。结肠 ACF 形成的 NOEL 被认为是 10ppm 的 MeIQx 与 NNK。这些结果表明,MeIQx 可能对肺肿瘤形成和结肠 ACF 形成有不同的阈剂量水平。作为一种强有力的肺致癌物,NNK 的预处理掩盖了 MeIQx 在肺部的作用,但在结肠中影响最小。CYP2A5 和 MGMT 的表达可能很重要,尤其是在肺部。本研究为遗传毒性致癌物的人类风险评估提供了重要建议。